Evidence map›Paper›PMID 35148312›Full record

ArticlePloS one2022

Performance of a novel rapid test for recent HIV infection among newly-diagnosed pregnant adolescent girls and young women in four high-HIV-prevalence districts-Malawi, 2017-2018.

Elfriede A Agyemang, Andrea A Kim, Trudy Dobbs, Innocent Zungu, Danielle Payne, Andrew D Maher, Kathryn Curran, Evelyn Kim, Hastings Kwalira, Henry Limula and 7 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 16 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Observational
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 3 institutions in 2 countries.

Elfriede A AgyemangDivision of Global HIV and TB, US Centers for Disease Control and Prevention, Atlanta, GA, United States of America.ORCID 0000-0003-1062-1460
Andrea A KimDivision of Global HIV and TB, US Centers for Disease Control and Prevention, Atlanta, GA, United States of America.
Trudy DobbsDivision of Global HIV and TB, US Centers for Disease Control and Prevention, Atlanta, GA, United States of America.
Innocent ZunguDivision of Global HIV and TB, US Centers for Disease Control and Prevention, Lilongwe, Malawi.
Danielle PayneDivision of Global HIV and TB, US Centers for Disease Control and Prevention, Lilongwe, Malawi.
Andrew D MaherInstitute for Global Health Sciences, University of California, San Francisco, San Francisco, CA, United States of America.
Kathryn CurranDivision of Global HIV and TB, US Centers for Disease Control and Prevention, Atlanta, GA, United States of America.
Evelyn KimDivision of Global HIV and TB, US Centers for Disease Control and Prevention, Lilongwe, Malawi.
Hastings KwaliraMinistry of Health and Population, Lilongwe, Malawi.
Henry LimulaMinistry of Health and Population, Lilongwe, Malawi.
Amitabh AdhikariDivision of Global HIV and TB, US Centers for Disease Control and Prevention, Atlanta, GA, United States of America.
Susie WeltyInstitute for Global Health Sciences, University of California, San Francisco, San Francisco, CA, United States of America.
James KanduluMinistry of Health and Population, Lilongwe, Malawi.
Rose NyirendaMinistry of Health and Population, Lilongwe, Malawi.
Andrew F AuldDivision of Global HIV and TB, US Centers for Disease Control and Prevention, Lilongwe, Malawi.
George W RutherfordInstitute for Global Health Sciences, University of California, San Francisco, San Francisco, CA, United States of America.ORCID 0000-0002-0707-8287
Bharat S ParekhDivision of Global HIV and TB, US Centers for Disease Control and Prevention, Atlanta, GA, United States of America.
Centers for Disease Control and Prevention · USMinistry of Health · MWUniversity of California, San Francisco · US

Funding

CGH CDC HHS U2G GH000977PEPFAR
6 · The paper itself

Abstract

Tests for recent HIV infection (TRI) distinguish recent from long-term HIV infections using markers of antibody maturation. The limiting antigen avidity enzyme immunoassay (LAg EIA) is widely used with HIV viral load (VL) in a recent infection testing algorithm (RITA) to improve classification of recent infection status, estimate population-level HIV incidence, and monitor trends in HIV transmission. A novel rapid test for recent HIV infection (RTRI), Asanté™, can determine HIV serostatus and HIV recency within minutes on a lateral flow device through visual assessment of test strip or reader device. We conducted a field-based laboratory evaluation of the RTRI among pregnant adolescent girls and young women (AGYW) attending antenatal clinics (ANC) in Malawi.We enrolled pregnant AGYW aged <25 years testing HIV-positive for the first time at their first ANC visit from 121 ANCs in four high-HIV burden districts. Consenting participants provided blood for recency testing using LAg EIA and RTRI, which were tested in central laboratories. Specimens with LAg EIA normalized optical density values ≤2.0 were classified as probable recent infections. RTRI results were based on: (1) visual assessment: presence of a long-term line (LT) indicating non-recent infection and absence of the line indicating recent infection; or (2) a reader; specimens with LT line intensity units <3.0 were classified as probable recent infections. VL was measured for specimens classified as a probable recent infections by either assay; those with HIV-1 RNA ≥1,000 copies/mL were classified as confirmed recent infections. We evaluated the performance of the RTRI by calculating correlation between RTRI and LAg EIA results, and percent agreement and kappa between RTRI and LAg EIA RITA results.Between November 2017 to June 2018, 380 specimens were available for RTRI evaluation; 376 (98.9%) were confirmed HIV-positive on RTRI. Spearman's rho between RTRI and LAg EIA was 0.72 indicating strong correlation. Percent agreement and kappa between RTRI- and LAg EIA-based RITAs were >90% and >0.65 respectively indicating substantial agreement between the RITAs.This was the first field evaluation of an RTRI in sub-Saharan Africa, which demonstrated good performance of the assay and feasibility of integrating RTRI into routine HIV testing services for real-time surveillance of recent HIV infection.

Indexed as

AdolescentAlgorithmsFemaleHIV-1HIV AntigensHIV InfectionsHumansImmunoassayMalawiPoint-of-Care SystemsPregnancyPregnant PeoplePrevalenceViral LoadYoung AdultHIV Antigens

Identifiers

PMID35148312
PMCPMC8836306
OpenAlexW4211092836

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.